Document Detail


Cardiac PET Perfusion Tracers: Current Status and Future Directions.
MedLine Citation:
PMID:  25234078     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PET myocardial perfusion imaging (MPI) is increasingly being used for noninvasive detection and evaluation of coronary artery disease. However, the widespread use of PET MPI has been limited by the shortcomings of the current PET perfusion tracers. The availability of these tracers is limited by the need for an onsite ((15)O water and (13)N ammonia) or nearby ((13)N ammonia) cyclotron or commitment to costly generators ((82)Rb). Owing to the short half-lives, such as 76 seconds for (82)Rb, 2.06 minutes for (15)O water, and 9.96 minutes for (13)N ammonia, their use in conjunction with treadmill exercise stress testing is either not possible ((82)Rb and (15)O water) or not practical ((13)N ammonia). Furthermore, the long positron range of (82)Rb makes image resolution suboptimal and its low myocardial extraction limits its defect resolution. In recent years, development of an (18)F-labeled PET perfusion tracer has gathered considerable interest. The longer half-life of (18)F (109 minutes) would make the tracer available as a unit dose from regional cyclotrons and allow use in conjunction with treadmill exercise testing. Furthermore, the short positron range of (18)F would result in better image resolution. Flurpiridaz F 18 is by far the most thoroughly studied in animal models and is the only (18)F-based PET MPI radiotracer currently undergoing clinical evaluation. Preclinical and clinical experience with Flurpiridaz F 18 demonstrated a high myocardial extraction fraction, high image and defect resolution, high myocardial uptake, slow myocardial clearance, and high myocardial-to-background contrast that was stable over time-important properties of an ideal PET MPI radiotracer. Preclinical data from other (18)F-labeled myocardial perfusion tracers are encouraging.
Authors:
Jamshid Maddahi; René R S Packard
Related Documents :
17562528 - The effect of cardiac ischemic preconditioning on rat left ventricular gene expression ...
15816328 - Nitric oxide "at heart": emerging paradigms after a decade.
19175358 - Transient limb ischaemia remotely preconditions through a humoral mechanism acting dire...
20084408 - Landiolol does not enhance the effect of ischemic preconditioning in isolated rat hearts.
6444828 - Natural history of left bundle-branch block.
10548208 - Cardiac output can be reliably measured noninvasively after coronary artery bypass graf...
Publication Detail:
Type:  REVIEW    
Journal Detail:
Title:  Seminars in nuclear medicine     Volume:  44     ISSN:  1558-4623     ISO Abbreviation:  Semin Nucl Med     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-9-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1264464     Medline TA:  Semin Nucl Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  333-343     Citation Subset:  -    
Copyright Information:
Copyright © 2014. Published by Elsevier Inc.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Psychosis and seizure disorder: challenges in diagnosis and treatment.
Next Document:  Cardiac PET Perfusion: Prognosis, Risk Stratification, and Clinical Management.